HORIZON PHARMACEUTICAL LLC
已退市CIK 1070698fmd_10NN8RWX4C64GXXC0ANYKJ3H8T制造业 · 医药制剂模板: 标准
覆盖范围: 2005年9月08日 至 2016年6月30日，共 33 个期间
| 项目 | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | – | – | – | – | 0 | 0 | 0 | 17 | 69 | 94 |
| 营业成本 | – | – | – | – | – | – | – | 2 | 9 | 13 |
| 毛利润 | – | – | – | – | – | – | – | 15 | 60 | 82 |
| 研发费用 | – | – | – | – | 9 | 15 | 21 | 29 | 43 | 59 |
| 营业费用合计 | – | – | – | – | 13 | 21 | 36 | 67 | 100 | 130 |
| 营业利润 | – | – | – | – | (13) | (21) | (36) | (52) | (40) | (48) |
| 利息费用 | – | – | – | – | 0 | 0 | 0 | 7 | 14 | 16 |
| 利息及投资收益 | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| 税前利润 | – | – | – | – | – | – | – | (69) | (52) | (65) |
| 所得税费用 | – | – | – | – | – | – | – | 0 | (0) | (0) |
| 持续经营净利润 | – | – | – | – | – | – | – | (69) | (52) | (64) |
| 净利润 | (1) | (4) | (8) | (9) | (19) | (37) | (39) | (69) | (53) | (65) |